NCT04100525

Brief Summary

Unemployment is particularly common among women with multiple sclerosis (MS). This study uses a vocational rehabilitation program involving neuropsychological testing as an intervention. The use of in-person feedback and case management following neuropsychological testing is compared to phone feedback only. Adherence to treatment and employment outcomes will be evaluated over three years.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
89

participants targeted

Target at P75+ for not_applicable multiple-sclerosis

Timeline
Completed

Started Apr 2016

Longer than P75 for not_applicable multiple-sclerosis

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
3.5 years until next milestone

First Submitted

Initial submission to the registry

September 20, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 24, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

February 18, 2021

Status Verified

February 1, 2021

Enrollment Period

3.8 years

First QC Date

September 20, 2019

Last Update Submit

February 16, 2021

Conditions

Keywords

EmploymentVocational Rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Employment

    Has there been a decrease in employment status (Yes/No)

    Approximately 12 months

Secondary Outcomes (1)

  • Adherence to Recommendations

    Approximately 12 months

Study Arms (2)

Standard Care

ACTIVE COMPARATOR

Participant received neuropsychological testing, report detailing cognitive strengths and weaknesses, tailored recommendations to address areas of weakness (including psychological and/or physical symptoms impacting work productivity). Participant received a copy of this report in the mail and a call from the psychologist to go over test findings and recommendations.

Behavioral: Neuropsychological testing intervention plus follow up

Experimental Treatment

EXPERIMENTAL

Participant received neuropsychological testing, report detailing cognitive strengths and weaknesses, tailored recommendations to address areas of weakness (including psychological and/or physical symptoms impacting work productivity). Participant then receives in-person feedback (and a copy of the report at this visit) and two calls from a care-coordinator research nurse at approximately 1 and 6 months post feedback, who asks participant whether they completed recommendations and assist participant in completing recommendations where possible (i.e., help find a provider, explanation of importance of completing recommendations, etc).

Behavioral: Neuropsychological testing intervention plus follow up

Interventions

Neuropsychological testing for women experiencing significant fatigue, mood, or cognitive symptoms. Feedback type and case management services varied depending on randomized group.

Experimental TreatmentStandard Care

Eligibility Criteria

Age18 Years - 64 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsStudy targeted females
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Female sex
  • Age between 18 and 64
  • Employed at least 20 hours per week
  • Confirmed diagnosis of MS

You may not qualify if:

  • Experiencing an MS exacerbation
  • Endorsing suicidal ideation or intent
  • Pregnant
  • Severe psychiatric disorder
  • History of traumatic brain injury
  • Dementia
  • Major neurological illness other than MS

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Frederick W Foley, Ph.D.

    Holy Name Medical Center, Ferkauf Graduate School of Psychology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants were informed that they would receive feedback but were not told whether it would be in person or by phone until after randomization. Participants were not informed that only one group received case management calls.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 20, 2019

First Posted

September 24, 2019

Study Start

April 1, 2016

Primary Completion

February 1, 2020

Study Completion

January 1, 2022

Last Updated

February 18, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share